Progressive Care Inc (RXMD)

[Jimmy Quick]

This is the real deal. Can't stop what the company is doing, none of us can, they have a great plan and have been executing it over the course of the last several years. It's happening in 2020.
$RXMD $40+ MILLION REVS, SEC FILING SOON, PROFITS, THE NEXT RITE-AID
REAL COMPANY - OTCQB – Penny Stock Exempt, 3 YEARS AUDITED FINANCIALS, Will be over 40+ MILLION NET ANNUAL REVS for 2020 – HUGE LONGTERM INVESTMENT POTENTIAL. Will be double in Revenues, scripts, and assets in FY 2020 from FY 2018 when it ran to $.27.
OH MY, HOW RXMD HAS GROWN UP OVER THE YEARS


What's happening for RXMD?

10 things specifically come to mind, and they keep generating more "Game Changers" by the week.

1. $SEC S-1 filing to occur in the month of May 2020 (See 2 below)


2. RXMD Doubles March Sales, Successfully Utilizing Its Market Leading Contactless RX Delivery Due to Covid-19 Pandemic

MIAMI, FL – April 15 2020 Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for March 2020, which featured breakthrough growth in total sales and a new Company record in total number of prescriptions filled on sharp market share gains:
· Consolidated monthly gross sales across all locations totaled $3.6 million, representing year-over-year growth of 105% compared to March 2019,
· Prescriptions filled during the month came in at 47,467, representing year-over-year growth of 76% compared to March 2019,
· Prescriptions filled hit a new all-time monthly record for the Company in March,
· “Ready, Set, PrEP” Program for HIV prevention launched,
· Seeing continued growth in services targeting non-profit organizations,
· Will file with SEC for fully reporting status.

3. 2020 1st Quarter Conference Call to Discuss Results on May 15th - COMPLETE

MIAMI, FL, May 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Friday, May 15th, 2020.
“COVID-19 has dramatically changed the economic landscape of all industries and few have been able to adapt and lead in the manner we have,” stated S. Parikh Mars, CEO. “We are looking forward to discussing the financial performance of the Company as well as all of the initiatives currently underway.”
In addition, interested parties may submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: [e-mail] by 5:00 PM EST on Wednesday, May 13th, 2020. Mr. Smith will compile a list of questions and submit them to the Company prior to the conference call. Which questions will be addressed will be based on the relevance to the shareholder base, and the question’s appropriateness in light of public disclosure rules.
To access the call:
Dial-In Number: 1-857-232-0157 Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/tag/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available https://progressivecareus.com/progressive-care-inc-investors-section/.

4. Progressive Care Announces Successful Expansion of PharmcoRX.com eCommerce Portal to Entire US

MIAMI, FL, April 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has expanded the scope of its new ecommerce portal (PharmcoRX.com) to serve the entire US domestic market. The Company started filling and shipping orders nationwide this week.
The PharmcoRX.com site includes online access to prescriptions, essential goods, personal protection equipment, guidance on COVID-19 prevention and care, information about custom compounding, and access to services for patients, payors, and providers.
“We are preparing for a large-scale uptick in order volume,” noted S. Parikh Mars, CEO of Progressive Care. “It’s also important for our shareholders to know that our decision to ramp up ecommerce at this time isn’t just about COVID-19. Certainly, the unusual context, with so many consumers conducting all of their activity online, acted as a motivating factor to move in this direction now, rather than later. But this step represents more than a simple short-term strategy. It’s a powerful evolutionary leap for Progressive Care – a natural escalation of our scope and reach as an emerging leader in the pharmacy and healthcare services marketplace.”
Management expects that the Company’s successful implementation of its ecommerce strategy will positively impact anticipated performance in coming quarters and overall in 2020.

5. Annual Shareholder Letter for 2020 Forecast and Goals – Done: Press Release 1/23/2020
Ms. Shital Mars, CEO shared the outlook for 2020 and highlights from 2019.

Progressive Care OUTLOOK
2020 Strategic Goals
• Achieve 60,000 prescriptions filled in a single month
• Strive to achieve over $44 million in sales
• Recognize performance bonuses for all 4 locations
• Consolidate locations to the Hallandale Beach location
• Expand market presence to account for all urban centers in Florida
• Secure additional not-for-profit healthcare contracts and long-term care facility relationships
• Achieve full enterprise profitability and earnings growth
• Launch RXMD Therapeutics exclusive line of CBD products
• Acquire software platform for the development of proprietary telemedicine product
• Develop backend healthcare administration platform for monetization of expertise in data analytics
• Become SEC-registered and fully reporting
• File an application to uplist to a national exchange

6. Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative Nutraceutical Products

MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary, RXMD Therapeutics Inc., specializing in cannabinoid-based and alternative therapy product lines.
“We are excited to make this official announcement, RXMD Therapeutics Inc. has been in the planning stages this past year” said S. Parikh Mars, CEO of Progressive Care Inc. “We believe we have finally found a pathway where we can provide cannabinoid and homeopathic products that meet our strict quality requirements while also being able to manage these therapies from a health and wellbeing perspective.”
Progressive Care Inc. will develop and produce proprietary cannabinoid and homeopathic products that will be solely offered from RXMD Therapeutics Inc. The first line of production will consist of tinctures, skin creams, roll-ons and gel capsules which are the dosage forms most easily managed by retail patients. RXMD Therapeutics brands will be tested for consistency and quality assurance prior to release and periodically thereafter.
The formation of RXMD Therapeutics Inc. was discussed with Progressive Care Inc.’s shareholders during the first quarter 2019 quarterly report conference call on May 15, 2019. The Company announced plans to market current CBD brands and leverage the cash buying customer base to fortify against insurance rate compression and increase profitability. The Company discussed plans to produce an exclusive line of products that incorporates the Company’s brand and mission to further develop its core market base and healthcare capabilities.

7. Progressive Care Reports Record $32M Revenues, 70% Jump in Gross Profits, Leadership in Contactless Prescription Delivery Accelerating Momentum

MIAMI, FL -- March 31, 2020 -- InvestorsHub NewsWire -- Progressive Care Inc. (RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is very excited to announce the release of the Company’s audited Annual Report for 2019. The Company posted record-breaking data, which was defined by sequential quarterly improvement throughout the year in all major financial performance metrics, including EBITDA profitability in Q4 2019. In addition, the Company is pleased to report that this momentum has continued to define results so far in 2020, as the Company sees market share gains based on its established leadership position in-home delivery and disease prevention protocols which have become a critical competitive advantage due to concerns over the spread of Coronavirus Disease 2019 (“COVID-19”).
S. Parikh Mars, CEO of Progressive Care, commented, “2019 was an extraordinary year for Progressive Care. We confronted difficult challenges and put together the most impressive stretch of performance in our history in response. Each quarter – each month – was better than the last and now defines a fresh context for 2020.”

8. Potential Partnership for Uplist

THEY are doing everything to expand their reach for revenues. Loving their approach to building this company and expanding it. Remember they have have some irons in the fire for a partnership.

FROM MARCH 31, 2020 CONFERENCE CALL TRANSCRIPT
Stuart Smith, SmallCapVoice Host

All right. Well let's wrap it up with this question then with such a robust acquisition strategy in your recent history, is there an acquisition plan in place for 2020?

Shital Mars, CEO ProgressiveCare

So we had a number of conversations and we've gotten into different points of our lives. We have different things standing out where we're negotiating on our lives and negotiating on other things and we're trying to bring other companies on board. We're also looking at partnerships for ourselves whereby may be and we're either preliminary but the thought process if a combination with another company that is already listed on a national exchange would be beneficial to us or combining our forces with another company that has a strong market presence, we are ready in negotiations with a couple of companies. We've put preliminary LOI out there and we're waiting response.

COVID-19 the crisis has put a hold on a lot of business development aspects, a lot of the company's business plans over the next 90 days for a lot of the companies were talking to our healthcare companies and so their primary concern right now is care and providing care. New York City has been pretty hit hard. A lot of metropolitan areas are being hit pretty hard. So that's their focus right now.

So we're just -- not at all moving pattern but trying to reach out and be very ginger with how we approach this situation because we want to make sure that we also are keeping our eyes on the delivery of care for our patients. So I think an acquisition is not necessarily probable in 2020 but we're hopeful that one of these that we have out there is going to close one. .

9. Progressive Care, Inc CEO Recognized by Forbes

Progressive Care, Inc CEO Recognized by Forbes as a Unique Leader

MIAMI – April 29, 2019 – InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Forbes in an article titled, A Unique Path Towards Leadership Creates a Unique Leader.

10. Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc. earning them $648,000 in refunds for FY 2019


ALL OF THIS COULD LEAD TO A SIMILAR SITUATION AS BELOW IN THE FUTURE IN TERMS OF VALUATION – AGAIN HUGE LONGTERM INVESTEMENT POTENTIAL
LOOK AT AMAZONS BUY OF PILLPACK for around $1 Billion, and PillPack revenues were $100 million. RXMD has a ton of revenues. Will be over $40 million net revenues for FY 2020.


MORE TIDBITS
REVENUE FAST FORWARD A YEAR


Penny Stock Exempt with low Share Structure


RXMD Retail Stores Commence Major Expansion Across Florida



CEO IS REALLY SMART



PHARMCORX HAS SMARTPACK, EXACT SAME AS AMAZON’S PILLPACK


3 YEARS AUDITED F/S


RXMD SERVICE PROVIDERS


THINGS ARE LINING UP JUST LIKE BEFORE WITH A HIGHER BASE POINT